Detalhe da pesquisa
1.
SARS-CoV-2 Inactivation in Aerosol by Means of Radiated Microwaves.
Viruses
; 15(7)2023 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515131
2.
Reply to Taylor et al. Comment on "Manna et al. SARS-CoV-2 Inactivation in Aerosol by Means of Radiated Microwaves. Viruses 2023, 15, 1443".
Viruses
; 15(10)2023 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37896888
3.
In Vitro Antiviral Activity of Hyperbranched Poly-L-Lysine Modified by L-Arginine against Different SARS-CoV-2 Variants.
Nanomaterials (Basel)
; 13(24)2023 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38132987
4.
Synergistic drug combinations designed to fully suppress SARS-CoV-2 in the lung of COVID-19 patients.
PLoS One
; 17(11): e0276751, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36355808
5.
Effective SARS-CoV-2 antiviral activity of hyperbranched polylysine nanopolymers.
Nanoscale
; 13(39): 16465-16476, 2021 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34553728
6.
Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains.
ACS Chem Biol
; 13(1): 253-266, 2018 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29235845
7.
Topical DermaVir vaccine targeting dendritic cells.
Curr Drug Deliv
; 3(1): 83-8, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16472097
8.
CD4+ T cell-mediated presentation of non-infectious HIV-1 virion antigens to HIV-specific CD8+ T cells.
Chin Med J (Engl)
; 119(19): 1629-38, 2006 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-17042976
9.
Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic ('virostatic') mechanisms.
AIDS
; 19(11): 1173-81, 2005 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-15990570
10.
Hydroxyurea exerts a cytostatic but not immunosuppressive effect on T lymphocytes.
AIDS
; 19(2): 137-44, 2005 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-15668538
11.
Control of viral rebound through therapeutic immunization with DermaVir.
AIDS
; 19(1): 35-43, 2005 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-15627031
12.
DermaVir: a novel topical vaccine for HIV/AIDS.
J Invest Dermatol
; 124(1): 160-9, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15654970
13.
Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potency.
AIDS Res Hum Retroviruses
; 21(4): 263-72, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15943568
14.
Fas, IL-7, and T cells: live and let die.
Blood
; 112(4): 930-1, 2008 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18684877
15.
Quantification of HIV-specific CD8 T cells by in vitro stimulation with inactivated viral particles.
AIDS
; 16(14): 1849-57, 2002 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-12351944
16.
A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study.
AIDS
; 17(1): 43-51, 2003 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-12478068
17.
Structured treatment interruptions in HIV/AIDS therapy.
Microbes Infect
; 4(2): 207-14, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11880054
18.
Strategies to decrease viral load rebound, and prevent loss of CD4 and onset of resistance during structured treatment interruptions.
Antivir Ther
; 9(1): 123-32, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15040544
19.
Vaccinia assay for the rapid detection of functional HIV-specific CD8+ cytotoxic T lymphocytes.
J Immunol Methods
; 276(1-2): 45-57, 2003 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12738358
20.
Gene therapy approaches to HIV infection.
Am J Pharmacogenomics
; 2(4): 245-52, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12421095